Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Week Liechtenstein.
Press releases published on March 9, 2026
Mar. 9, 2026
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Indeterminate
GlobeNewswire
Mar. 9, 2026
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 9, 2026
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
Indeterminate
GlobeNewswire
Mar. 9, 2026
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 9, 2026
Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
Indeterminate
GlobeNewswire
Mar. 9, 2026
Flow Shares Ecosystem Update; Announces Joint Resolution with Binance
Indeterminate
GlobeNewswire
Mar. 9, 2026
Frequency Holdings (OTC FRQN) Announces Verified in Microsoft AI Cloud Partner Program
Indeterminate
GlobeNewswire
Mar. 9, 2026
Enrollment Opens for K12-Powered Virtual Public Schools Serving Students Across Alabama
Indeterminate
GlobeNewswire
Mar. 9, 2026
Enrollment Opens for K12-Powered Virtual Public Schools Serving Students Across Wisconsin
Indeterminate
GlobeNewswire
Mar. 9, 2026
GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF
Indeterminate
GlobeNewswire
Mar. 9, 2026
GENFIT reçoit la désignation Orphan Drug de la FDA pour NTZ dans le traitement de l’ACLF
Indeterminate
GlobeNewswire
Mar. 9, 2026
Darktrace Appoints Ed Jennings as President and CEO
Indeterminate
GlobeNewswire
Mar. 9, 2026
Dstillery’s Melinda Han Williams Named to ADWEEK’s AI Power 50
Indeterminate
GlobeNewswire
Mar. 9, 2026
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026
Indeterminate
GlobeNewswire
Mar. 9, 2026
Valneva publiera ses résultats financiers consolidés 2025 le 18 mars 2026
Indeterminate
GlobeNewswire